Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 138 Breast Neoplasms 95 Neoplasms 8 Neoplasm Metastasis 6 Breast Neoplasms, Male 6 Advanced Breast Cancer 4 Salivary Gland Neoplasms 3 Prostate Adenocarcinoma 3 Triple Negative Breast Neoplasms 2 Recurrence 2 Osteoporosis 2 Leiomyoma 2 Infertility 2 Advanced Prostate Cancer 2 Stage I Prostate Adenocarcinoma AJCC v7 1 Sexual Dysfunctions, Psychological 1 Sexual Dysfunction, Physiological 1 Sarcopenia 1 Radiation Injuries 1 Primary Ovarian Insufficiency 1 Primary Dysautonomias 1 Patients With T1-4 Advanced Prostate Cancer 1 Patient Compliance 1 PSA Level Greater Than Two 1 Ovarian Neoplasms 1 Osteitis Deformans 1 Myofibroma 1 Lymphatic Metastasis 1 Kidney Diseases 1 Inflammatory Breast Neoplasms 1

Interventions

ribociclib 1 Tretinoin 1 Letrozole 1 Goserelin 1 Drug Therapy 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

HER2 Negative Breast Cancer × Goserelin × Clear all

NCT06953882 2026-05-26

SELECT

Yale University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡